|
|
||||||||||
![]() |
||||||||||
|
| Table 1: | ||
|
Causes
of Hypocalcemia
|
||
|
Decreased
Entry of
Calcium into the Circulation |
Increased
Loss of
Calcium from the Circulation |
Other
Causes
|
|
|
|
| CaSR = calcium-sensing receptor; PTH = parathyroid hormone; EDTA = ethylenediaminetetraacetic acid | ||
|
|||||||||
| Table 3: | |
|
iPTH
Findings In Hypocalcemic Disorders
|
|
|
Disease
|
iPTH
Level
|
| Hypoparathyroidism | Mostly reduced, occasionally normal |
| Pseudohypoparathyroidism | Elevated |
| Vitamin D abnormalities | Elevated |
| Hypomagnesemia | Low, normal, or high |
| Autosomal dominant hypocalcemia | Normal |
| Table 4: | ||
|
Oral
Calcium Preparations
|
||
|
Calcium
Preparation |
Calcium
Content Per Pill |
Pill
Size |
|
Calcium
carbonate
|
250
mg
|
650
mg
|
|
Calcium
gluconate
|
90
mg
|
1000
mg
|
|
Calcium
citrate
|
200
mg
|
950
mg
|
|
Calcium
lactate
|
60
mg
|
300
mg
|
| Table 5: | ||
|
Vitamin
D Preparations
|
||
|
Vitamin
D Preparation
|
Half-Life
|
Form
of Therapy
|
| 1,25-Dihydroxycholecalciferol Rocaltrol Calcijex |
2-6
h
|
Capsule
0.25, 0.5 µg Injection 1 µg/mL 2 µg/mL |
| 25-hydroxycholecalciferol Calderol (requires activation in the kidneys) Ergocalciferol (Vitamin D2) Calciferol Drisdol |
12-22
d
Long (months) |
Capsule
20, 50 µg Capsule 1.25 mg-50000 IU Solution 12.5 mg/mL Drops 200 µg/mL-8000 IU |
| Cholecalciferol
(Vitamin D3) Delta-D |
Long
(months)
|
Tablet 400, 1000 IU |
|
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this web site. |
|
Copyright
2004 The Cleveland Clinic Foundation
|